# BPC-157 TB-500 FAQ: Mechanisms, Dosing, Safety, and Legal Status

> BPC-157 TB-500 questions answered from the literature: what the blend is, how the two peptides work, why there is no validated dose, the tumor-signal safety concern, and the FDA 503A status. Cited, plain answers — not medical advice.

Twenty-five plain answers, each pulled from the component literature or the regulatory file, with the combination's missing evidence kept visible.

## Definitions and the blend



## Mechanism



## Evidence and efficacy



## Dosing and handling



## Safety



## Legal status and access



---

A hand-drawn lab notebook on the BPC-157 TB-500 blend — each component study inked from its source and the missing combination trial circled in the margin in red, with no clinic behind the page and nothing here dispensed or sold.